Company Filing History:
3 out of 505 
1 out of 3 
1 out of 3 Years Active: 2003-2012
Title: The Innovative Contributions of Gilad Gallili in Vaccine Development
Introduction
Gilad Gallili, an accomplished inventor based in Jerusalem, Israel, is recognized for his significant contributions to the field of biotechnology, particularly in vaccine development. With six patents to his name, Gallili's work revolves around harnessing adenoviral proteins for use in immunization strategies.
Latest Patents
Among his most notable inventions is a series of patents focused on subunits of the adenovirus fiber protein. These patents describe a nucleic acid sequence encoding a fragment of the adenovirus fiber capsid protein, which includes a DNA construct featuring a replicable expression vector alongside at least one heterologous nucleic acid. His innovations also encompass recombinant proteins composed of fragments of the adenovirus fiber capsid protein, emphasizing the C-terminal knob and part of the shaft domain of these proteins. Specifically, his patents outline the use of recombinant proteins as active ingredients in vaccination compositions aimed at imparting immunity to animals against adenoviral infections, as well as methods for vaccinating domestic birds against such infections.
Career Highlights
Gallili has had an impactful career, having worked with prominent pharmaceutical companies. Notably, he was part of Teva Pharmaceutical Industries Limited and Abic Biological Laboratories Ltd. During his tenure in these organizations, he contributed to advancements in medical research and vaccine development, highlighting his commitment to public health.
Collaborations
In his research endeavors, Gallili has collaborated with notable colleagues, including Norbert Frydman and Jacob Pitcovski. These collaborations have been instrumental in driving forward key projects, enriching the collective expertise in the field of biotech and vaccine research.
Conclusion
Gilad Gallili's innovative spirit and dedication to vaccine research make him a prominent figure in biotechnology. His patents not only advance scientific understanding but also contribute to the development of effective strategies for combating viral infections in both animals and humans. As he continues to explore new frontiers in immunology, Gallili's work remains critical to the advancement of public health initiatives.